In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles

Hua Zhang, Elizabeth S. Ingham, M. Karen J Gagnon, Lisa M. Mahakian, Jingfei Liu, Josquin L. Foiret, Juergen K. Willmann, Katherine W. Ferrara

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Nucleolin (NCL) plays an important role in tumor vascular development. An increased endothelial expression level of NCL has been related to cancer aggressiveness and prognosis and has been detected clinically in advanced tumors. Here, with a peptide targeted to NCL (F3 peptide), we created an NCL-targeted microbubble (MB) and compared the performance of F3-conjugated MBs with non-targeted (NT) MBs both in vitro and in vivo. In an in vitro study, F3-conjugated MBs bound 433 times more than NT MBs to an NCL-expressing cell line, while pretreating cells with 0.5 mM free F3 peptide reduced the binding of F3-conjugated MBs by 84%, n = 4, p < 0.001. We then set out to create a method to extract both the tumor wash-in and wash-out kinetics and tumor accumulation following a single injection of targeted MBs. In order to accomplish this, a series of ultrasound frames (a clip) was recorded at the time of injection and subsequent time points. Each pixel within this clip was analyzed for the minimum intensity projection (MinIP) and average intensity projection (AvgIP). We found that the MinIP robustly demonstrates enhanced accumulation of F3-conjugated MBs over the range of tumor diameters evaluated here (2–8 mm), and the difference between the AvgIP and the MinIP quantifies inflow and kinetics. The inflow and clearance were similar for unbound F3-conjugated MBs, control (non-targeted) and scrambled control agents. Targeted agent accumulation was confirmed by a high amplitude pulse and by a two-dimensional Fourier Transform technique. In summary, F3-conjugated MBs provide a new imaging agent for ultrasound molecular imaging of cancer vasculature, and we have validated metrics to assess performance using low mechanical index strategies that have potential for use in human molecular imaging studies.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalBiomaterials
Volume118
DOIs
StatePublished - Feb 1 2017

Fingerprint

Molecular imaging
Microbubbles
Molecular Imaging
Tumors
Ultrasonography
Ultrasonics
Peptides
Neoplasms
Surgical Instruments
Kinetics
Injections
Fourier transforms
Fourier Analysis
Pixels
Cells
nucleolin
Imaging techniques
Blood Vessels
Cell Line

Keywords

  • Angiogenesis
  • In vivo
  • Molecular imaging
  • Nucleolin
  • Peptide
  • Ultrasound contrast agents

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Zhang, H., Ingham, E. S., Gagnon, M. K. J., Mahakian, L. M., Liu, J., Foiret, J. L., ... Ferrara, K. W. (2017). In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles. Biomaterials, 118, 63-73. https://doi.org/10.1016/j.biomaterials.2016.11.026

In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles. / Zhang, Hua; Ingham, Elizabeth S.; Gagnon, M. Karen J; Mahakian, Lisa M.; Liu, Jingfei; Foiret, Josquin L.; Willmann, Juergen K.; Ferrara, Katherine W.

In: Biomaterials, Vol. 118, 01.02.2017, p. 63-73.

Research output: Contribution to journalArticle

Zhang, H, Ingham, ES, Gagnon, MKJ, Mahakian, LM, Liu, J, Foiret, JL, Willmann, JK & Ferrara, KW 2017, 'In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles', Biomaterials, vol. 118, pp. 63-73. https://doi.org/10.1016/j.biomaterials.2016.11.026
Zhang, Hua ; Ingham, Elizabeth S. ; Gagnon, M. Karen J ; Mahakian, Lisa M. ; Liu, Jingfei ; Foiret, Josquin L. ; Willmann, Juergen K. ; Ferrara, Katherine W. / In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles. In: Biomaterials. 2017 ; Vol. 118. pp. 63-73.
@article{aac8f473f9f24cd78d884190c94be097,
title = "In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles",
abstract = "Nucleolin (NCL) plays an important role in tumor vascular development. An increased endothelial expression level of NCL has been related to cancer aggressiveness and prognosis and has been detected clinically in advanced tumors. Here, with a peptide targeted to NCL (F3 peptide), we created an NCL-targeted microbubble (MB) and compared the performance of F3-conjugated MBs with non-targeted (NT) MBs both in vitro and in vivo. In an in vitro study, F3-conjugated MBs bound 433 times more than NT MBs to an NCL-expressing cell line, while pretreating cells with 0.5 mM free F3 peptide reduced the binding of F3-conjugated MBs by 84{\%}, n = 4, p < 0.001. We then set out to create a method to extract both the tumor wash-in and wash-out kinetics and tumor accumulation following a single injection of targeted MBs. In order to accomplish this, a series of ultrasound frames (a clip) was recorded at the time of injection and subsequent time points. Each pixel within this clip was analyzed for the minimum intensity projection (MinIP) and average intensity projection (AvgIP). We found that the MinIP robustly demonstrates enhanced accumulation of F3-conjugated MBs over the range of tumor diameters evaluated here (2–8 mm), and the difference between the AvgIP and the MinIP quantifies inflow and kinetics. The inflow and clearance were similar for unbound F3-conjugated MBs, control (non-targeted) and scrambled control agents. Targeted agent accumulation was confirmed by a high amplitude pulse and by a two-dimensional Fourier Transform technique. In summary, F3-conjugated MBs provide a new imaging agent for ultrasound molecular imaging of cancer vasculature, and we have validated metrics to assess performance using low mechanical index strategies that have potential for use in human molecular imaging studies.",
keywords = "Angiogenesis, In vivo, Molecular imaging, Nucleolin, Peptide, Ultrasound contrast agents",
author = "Hua Zhang and Ingham, {Elizabeth S.} and Gagnon, {M. Karen J} and Mahakian, {Lisa M.} and Jingfei Liu and Foiret, {Josquin L.} and Willmann, {Juergen K.} and Ferrara, {Katherine W.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.biomaterials.2016.11.026",
language = "English (US)",
volume = "118",
pages = "63--73",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles

AU - Zhang, Hua

AU - Ingham, Elizabeth S.

AU - Gagnon, M. Karen J

AU - Mahakian, Lisa M.

AU - Liu, Jingfei

AU - Foiret, Josquin L.

AU - Willmann, Juergen K.

AU - Ferrara, Katherine W.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Nucleolin (NCL) plays an important role in tumor vascular development. An increased endothelial expression level of NCL has been related to cancer aggressiveness and prognosis and has been detected clinically in advanced tumors. Here, with a peptide targeted to NCL (F3 peptide), we created an NCL-targeted microbubble (MB) and compared the performance of F3-conjugated MBs with non-targeted (NT) MBs both in vitro and in vivo. In an in vitro study, F3-conjugated MBs bound 433 times more than NT MBs to an NCL-expressing cell line, while pretreating cells with 0.5 mM free F3 peptide reduced the binding of F3-conjugated MBs by 84%, n = 4, p < 0.001. We then set out to create a method to extract both the tumor wash-in and wash-out kinetics and tumor accumulation following a single injection of targeted MBs. In order to accomplish this, a series of ultrasound frames (a clip) was recorded at the time of injection and subsequent time points. Each pixel within this clip was analyzed for the minimum intensity projection (MinIP) and average intensity projection (AvgIP). We found that the MinIP robustly demonstrates enhanced accumulation of F3-conjugated MBs over the range of tumor diameters evaluated here (2–8 mm), and the difference between the AvgIP and the MinIP quantifies inflow and kinetics. The inflow and clearance were similar for unbound F3-conjugated MBs, control (non-targeted) and scrambled control agents. Targeted agent accumulation was confirmed by a high amplitude pulse and by a two-dimensional Fourier Transform technique. In summary, F3-conjugated MBs provide a new imaging agent for ultrasound molecular imaging of cancer vasculature, and we have validated metrics to assess performance using low mechanical index strategies that have potential for use in human molecular imaging studies.

AB - Nucleolin (NCL) plays an important role in tumor vascular development. An increased endothelial expression level of NCL has been related to cancer aggressiveness and prognosis and has been detected clinically in advanced tumors. Here, with a peptide targeted to NCL (F3 peptide), we created an NCL-targeted microbubble (MB) and compared the performance of F3-conjugated MBs with non-targeted (NT) MBs both in vitro and in vivo. In an in vitro study, F3-conjugated MBs bound 433 times more than NT MBs to an NCL-expressing cell line, while pretreating cells with 0.5 mM free F3 peptide reduced the binding of F3-conjugated MBs by 84%, n = 4, p < 0.001. We then set out to create a method to extract both the tumor wash-in and wash-out kinetics and tumor accumulation following a single injection of targeted MBs. In order to accomplish this, a series of ultrasound frames (a clip) was recorded at the time of injection and subsequent time points. Each pixel within this clip was analyzed for the minimum intensity projection (MinIP) and average intensity projection (AvgIP). We found that the MinIP robustly demonstrates enhanced accumulation of F3-conjugated MBs over the range of tumor diameters evaluated here (2–8 mm), and the difference between the AvgIP and the MinIP quantifies inflow and kinetics. The inflow and clearance were similar for unbound F3-conjugated MBs, control (non-targeted) and scrambled control agents. Targeted agent accumulation was confirmed by a high amplitude pulse and by a two-dimensional Fourier Transform technique. In summary, F3-conjugated MBs provide a new imaging agent for ultrasound molecular imaging of cancer vasculature, and we have validated metrics to assess performance using low mechanical index strategies that have potential for use in human molecular imaging studies.

KW - Angiogenesis

KW - In vivo

KW - Molecular imaging

KW - Nucleolin

KW - Peptide

KW - Ultrasound contrast agents

UR - http://www.scopus.com/inward/record.url?scp=85002545405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002545405&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2016.11.026

DO - 10.1016/j.biomaterials.2016.11.026

M3 - Article

VL - 118

SP - 63

EP - 73

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -